W
Won Chang Shin
Researcher at Inje University
Publications - 34
Citations - 474
Won Chang Shin is an academic researcher from Inje University. The author has contributed to research in topics: Abdominal pain & Odds ratio. The author has an hindex of 11, co-authored 34 publications receiving 404 citations.
Papers
More filters
Journal ArticleDOI
Bedside index for severity in acute pancreatitis: comparison with other scoring systems in predicting severity and organ failure.
Ji Young Park,Tae Joo Jeon,Tae Hwan Ha,Jin Tae Hwang,Dong Hyun Sinn,Tae-Hoon Oh,Won Chang Shin,Won-Choong Choi +7 more
TL;DR: The BISAP predicts severity, death, and especially organ failure in acute pancreatitis as well as APACHE-II does and better than Ranson criteria, CTSI, CRP, hematocrit, and BMI.
Journal ArticleDOI
Emerging toxin A-B+ variant strain of Clostridium difficile responsible for pseudomembranous colitis at a tertiary care hospital in Korea
TL;DR: Results revealed the possible emergence of tCDA-tcdB+ C. difficile strains in Korea, and these variant strains could evoke a higher rate of PMC than tcdA+tCDB+ strains.
Journal ArticleDOI
AIMS65 scoring system is comparable to Glasgow-Blatchford score or Rockall score for prediction of clinical outcomes for non-variceal upper gastrointestinal bleeding.
TL;DR: The AIMS65 score in NVUGI bleeding patients was comparable to the GBS or Rockall scoring systems when predicting the mortality, rebleeding, or ICU admission, and it is recommended to use the AIMs65 in daily practice.
Journal ArticleDOI
Clinical factors predicting for neoplastic transformation of gastric hyperplastic polyps
Hwa Mi Kang,Tae Hoon Oh,Ji Young Seo,Tae Joo Joen,Dong Dae Seo,Won Chang Shin,Won Choong Choi,Jung Yeon Kim +7 more
TL;DR: Neoplastic transformation of gastric HPs had significant relationships with 1 cm in size, pedunculated shape, postgastectomy state, and synchronous neoplastic lesion" and endoscopic polypectomy should be considered in these HPs to avoid the risk of missing HPs with neoplastics potential.
Journal ArticleDOI
Lafutidine versus Lansoprazole in Combination with Clarithromycin and Amoxicillin for One versus Two Weeks for Helicobacter pylori Eradication in Korea
Nayoung Kim,Soo Heon Park,Geom Seog Seo,Sang Woo Lee,Jae Woo Kim,Kwang Jae Lee,Won Chang Shin,Tae Nyeun Kim,Moo In Park,Jong Jae Park,Su Jin Hong,Ki Nam Shim,Sang Wook Kim,Yong Woon Shin,Young Woon Chang,Hoon Jai Chun,Ok Jae Lee,Won Joong Jeon,Chan Guk Park,Chang Min Cho,Cheol Hee Park,Sun Young Won,Gin Hyug Lee,Kyung Sik Park,Jeong Eun Shin,Heung Up Kim,Joon Yong Park,Hiun Suk Chae,Geun Am Song,Jae Gyu Kim,Byung Chul Yoon,Sang-Yong Seol,Hyun Chae Jung,In-Sik Chung +33 more
TL;DR: The aim of the present study was to test the efficacy of 7‐ or 14‐day lafutidine–clarithromycin–amoxicillin therapy versus a lansoprazole‐based regimen for Helicobacter pylori eradication.